ERYTECH provides business update and financial results for the full year 2014 admERY March 30, 2015 Newsroom ERYTECH provides a business update and reports its financial results for the period ending December 31, 2014. You Might Also Like ERYTECH announces oral presentations of GRASPA® Phase III results at ASCO and EHA annual meetings May 20, 2015 ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer December 14, 2020 ERYTECH Presents TRYbeCA-1 Trial-in-Progress Poster at the 2019 ASCO GI Annual Meeting January 18, 2019
ERYTECH announces oral presentations of GRASPA® Phase III results at ASCO and EHA annual meetings May 20, 2015
ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer December 14, 2020
ERYTECH Presents TRYbeCA-1 Trial-in-Progress Poster at the 2019 ASCO GI Annual Meeting January 18, 2019
